Nestlé invests in US brain food maker: ‘This is a big strategic move for us’
Two months after Abbott Nutrition described brain food research as “one of our top global priorities”, Nestlé Health Science has acquired a stake in Accera, the US firm behind Axona, a medical food targeted at people with mild to moderate Alzheimer’s.